Hair loss risk goes up on GLP-1 drugs, BMJ study finds
Original article ↗B.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.032
4,132 articles tracked
7-day bias trend
LcenterR
Article Excerpt
The BMJ study examined over 50,000 people with Type 2 diabetes taking GLP-1 receptor stimulants, comparing them with patients using other diabetes drugs such as SGLT-2 and DPP-4.
Read full article at Global News ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
pending
Jul 23, 2026